Scholarlink

Background <p>Intestinal ultrasound (IUS) is a non-invasive, accurate tool for monitoring inflammatory bowel disease (IBD), with growing adoption in the United States for real-time disease management within treat-to-target algorithms. While international studies highlight strong patient support for IUS, U.S.-based data on patient preferences and engagement are limited.</p> Aims <p>This cross-sectional observational study, conducted at two academic IBD centers in the U.S., assessed patient experiences with IUS and preferences for disease monitoring.</p> Methods <p>Adults with Crohn’s disease (CD) and ulcerative colitis (UC) seen for a routine visit were selected to undergo IUS-driven care or non-IUS-driven care, at the discretion of their provider. Participants then completed a 20-item survey, which included Likert scales for comparing disease-monitoring modalities, as well as measures of patient engagement (Patient Activation Measure (PAM-13), Morisky Medication Adherence Scale (MMAS-4)), and disease activity. Electronic health records were reviewed for clinical data.</p> Results <p>Of 326 patients (209 (64.1%) with CD; 117 (35.9%) with UC), 219 (67.2%) were IUS exposed (underwent IUS-driven care on the date of survey or previously) and 107 (32.8%) were IUS naïve. 133 (60.7%) IUS-exposed participants expressed a strong preference for IUS when comparing disease-monitoring modalities, with 153 (69.9%) reporting no discomfort. 225/326 (69.0%) expressed the strongest confidence in colonoscopy. 101 (46.1%) IUS-exposed participants expressed stronger confidence in IUS vs. blood work (96; 43.8%), stool studies (78; 35.6%), and other cross-sectional imaging (79; 36.1%).</p> Conclusion <p>IUS is highly acceptable, well tolerated, and preferred by our U.S. population. These findings support the implementation of IUS as a patient-centric monitoring tool.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study

  • 期刊论文

  • 发表日期：

    2025年9月18日

查看全文
  • Emily Gore,
  • Christopher Femino,
  • Illya Aronskyy,
  • Alexander Miller,
  • Sara R. Zelman,
  • Michael W. Winter,
  • Michael T. Dolinger

摘要

Background

Intestinal ultrasound (IUS) is a non-invasive, accurate tool for monitoring inflammatory bowel disease (IBD), with growing adoption in the United States for real-time disease management within treat-to-target algorithms. While international studies highlight strong patient support for IUS, U.S.-based data on patient preferences and engagement are limited.

Aims

This cross-sectional observational study, conducted at two academic IBD centers in the U.S., assessed patient experiences with IUS and preferences for disease monitoring.

Methods

Adults with Crohn’s disease (CD) and ulcerative colitis (UC) seen for a routine visit were selected to undergo IUS-driven care or non-IUS-driven care, at the discretion of their provider. Participants then completed a 20-item survey, which included Likert scales for comparing disease-monitoring modalities, as well as measures of patient engagement (Patient Activation Measure (PAM-13), Morisky Medication Adherence Scale (MMAS-4)), and disease activity. Electronic health records were reviewed for clinical data.

Results

Of 326 patients (209 (64.1%) with CD; 117 (35.9%) with UC), 219 (67.2%) were IUS exposed (underwent IUS-driven care on the date of survey or previously) and 107 (32.8%) were IUS naïve. 133 (60.7%) IUS-exposed participants expressed a strong preference for IUS when comparing disease-monitoring modalities, with 153 (69.9%) reporting no discomfort. 225/326 (69.0%) expressed the strongest confidence in colonoscopy. 101 (46.1%) IUS-exposed participants expressed stronger confidence in IUS vs. blood work (96; 43.8%), stool studies (78; 35.6%), and other cross-sectional imaging (79; 36.1%).

Conclusion

IUS is highly acceptable, well tolerated, and preferred by our U.S. population. These findings support the implementation of IUS as a patient-centric monitoring tool.